Antipsychotic Drugs Market Size, Share & Industry Analysis, By Disease (Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, and Others), By Drug (Risperidone, Quetiapine, Olanzapine, Aripiprazole, Brexpiprazole, Paliperidone Palmitate, and Others), By Therapeutic Class (First Generation, Second Generation, and Third Generation), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI101390

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Growth Rate	CAGR of 5.4% from 2024-2032
Unit	Value (USD billion)
Segmentation	By Disease Schizophrenia Bipolar Disorder Unipolar Depression Dementia Others
	By Drug Risperidone Quetiapine Olanzapine Aripiprazole Brexpiprazole Paliperidone Palmitate Others
	By Therapeutic Class First Generation Second Generation Third Generation
	By Distribution Channel Hospital Pharmacies Drug Stores & Retail Pharmacies Online Pharmacies
	By Region North America (By Disease, By Drug, By Therapeutic Class, By Distribution Channel, By Country) U.S. (By Disease) Canada (By Disease) Europe (By Disease, By Drug, By Therapeutic Class, By Distribution Channel, By Country/Sub-Region) Germany (By Disease) U.K. (By Disease) France (By Disease) Italy (By Disease) Spain (By Disease) Scandinavia (By Disease) Rest of Europe (By Disease) Asia Pacific (By Disease, By Drug, By Therapeutic Class, By Distribution Channel, By Country/Sub-Region) China (By Disease) Japan (By Disease) India (By Disease) Australia (By Disease) Southeast Asia (By Disease) Rest of Asia Pacific (By Disease) Latin America (By Disease, By Drug, By Therapeutic Class, By Distribution Channel, By Country/Sub-Region) Brazil (By Disease) Mexico (By Disease) Rest of Latin America (By Disease) Middle East & Africa (By Disease, By Drug, By Therapeutic Class, By Distribution Channel, By Country/Sub-Region) GCC (By Disease) South Africa (By Disease) Rest of Middle East & Africa (By Disease)